申请人:CHEMOCENTRYX, INC.
公开号:US20170114017A1
公开(公告)日:2017-04-27
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
提供了一些能够调节C5a受体的化合物。这些化合物是取代的哌啶类化合物,并且可用于制药组合物、治疗涉及C5a受体病理激活的疾病和疾病的方法。